View all news and updates >

CNF’s Statement on the FDA’s May 31st CBD Hearing

Posted on:

On May 31st, 2019, the FDA held a public hearing, “to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.”

In advance of this hearing, the CNF Board of Directors formally submitted the following statement to the FDA.